Athenex receives post-confirmation exclusivity extension

By Sarah Lizee

Olympia, Wash., Sept. 18 – Athenex, Inc. secured an extension of its exclusive periods to file and solicit votes on a Chapter 11 plan, according to an order filed Monday with the U.S. Bankruptcy Court for the Southern District of Texas.

Specifically, the court extended the exclusive plan filing period through Dec. 11 from Sept. 11 and the exclusive solicitation period through Feb. 8 from Nov. 10.

As previously reported, Athenex has sold substantially all of its assets and filed a plan of liquidation. The plan was confirmed on Sept. 12.

The company said it sought the extension out of an abundance of caution.

Athenex is a clinical-stage biopharmaceutical company with headquarters in Buffalo, N.Y. The company filed bankruptcy on May 14 under Chapter 11 case number 23-90295.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.